Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
American College of Cardiology
Biotech
NewAmsterdam shares more data on lipid-lowering Amgen castoff
NewAmsterdam Pharma is sharing more phase 2 obicetrapib data, including an analysis of a predictor of residual risk for future cardiovascular events.
Gabrielle Masson
Apr 9, 2024 5:30am
ACC: Efficacy ticks down a smidge for Ionis' metabolic drug
Apr 7, 2024 9:45am
ACC: Medtronic touts 3-year renal denervation data
Apr 4, 2022 12:45pm
Cytokinetics preps omecamtiv for support role in heart failure
May 17, 2021 8:00am
MyoKardia cuts heart stress signs in biomarker study
Mar 30, 2020 10:30am
10-year stent data similar to CABG, but less durable
Mar 30, 2020 9:00am
